1. Home
  2. MDGL vs RH Comparison

MDGL vs RH Comparison

Compare MDGL & RH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • RH
  • Stock Information
  • Founded
  • MDGL 2011
  • RH 1979
  • Country
  • MDGL United States
  • RH United States
  • Employees
  • MDGL N/A
  • RH N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • RH Other Specialty Stores
  • Sector
  • MDGL Health Care
  • RH Consumer Discretionary
  • Exchange
  • MDGL Nasdaq
  • RH Nasdaq
  • Market Cap
  • MDGL 6.4B
  • RH 7.6B
  • IPO Year
  • MDGL N/A
  • RH 1998
  • Fundamental
  • Price
  • MDGL $340.14
  • RH $434.73
  • Analyst Decision
  • MDGL Buy
  • RH Buy
  • Analyst Count
  • MDGL 14
  • RH 16
  • Target Price
  • MDGL $351.67
  • RH $419.53
  • AVG Volume (30 Days)
  • MDGL 392.5K
  • RH 459.5K
  • Earning Date
  • MDGL 02-26-2025
  • RH 12-12-2024
  • Dividend Yield
  • MDGL N/A
  • RH N/A
  • EPS Growth
  • MDGL N/A
  • RH N/A
  • EPS
  • MDGL N/A
  • RH 3.51
  • Revenue
  • MDGL $76,813,000.00
  • RH $3,106,607,000.00
  • Revenue This Year
  • MDGL N/A
  • RH $8.81
  • Revenue Next Year
  • MDGL $195.95
  • RH $14.17
  • P/E Ratio
  • MDGL N/A
  • RH $123.69
  • Revenue Growth
  • MDGL N/A
  • RH 1.41
  • 52 Week Low
  • MDGL $168.25
  • RH $212.43
  • 52 Week High
  • MDGL $368.29
  • RH $457.26
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 61.81
  • RH 59.38
  • Support Level
  • MDGL $266.44
  • RH $424.21
  • Resistance Level
  • MDGL $343.97
  • RH $455.84
  • Average True Range (ATR)
  • MDGL 20.88
  • RH 12.50
  • MACD
  • MDGL 2.00
  • RH 1.75
  • Stochastic Oscillator
  • MDGL 92.59
  • RH 66.83

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

About RH RH

RH is a luxury furniture and lifestyle retailer operating in the $134 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 19 restaurant locations. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade by expanding abroad, with its World of RH digital platform (highlighting offerings outside of home furnishings), and with offerings in bespoke furniture, architecture, media, and more.

Share on Social Networks: